Neuland Laboratories Share Price

Neuland Laboratories (INR)17147.7500.1   (3%)

Exchange ScripsBSE524558NSENEULANDLABISININE794A01010

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Neuland Laboratories Performance

Market performance
Open price16813.4
High17210
Volumes43954
Prev Close17147.7
Low16469.6
Closing date2024-12-03
Historical performance
1 Year High17234.90
3 Year High17234.90
5 Year High17234.90
1 Year Low4926.05
3 Year Low967.00
5 Year Low245.75

Neuland Laboratories Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
21939
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
73.32
Dividend Yield
Dividend Yield
0.01 %

Neuland Laboratories Investment Returns

1 Year
219.3%
3 Years
859.3%
5 Years
3842.5%
10 Years
3776.9%

Neuland Laboratories Technicals

IndicatorsValueSignal
5-DMA16633.34Bullish
10-DMA15752.38Bullish
20-DMA15209.98Bullish
50-DMA14110.43Bullish
100-DMA12511.34Bullish
200-DMA9627.24Bullish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters1111111111
Foreign Investors22222
Domestic Investors99999
Public Investors3455629066286052771226813
Government11111

Neuland Laboratories Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income1259721161
Operating Profit4751281614471629
Interest140131135179
Depreciation597528490397
Profit Before Tax401421578221053
Consolidated Net Profit30011635638806
Adjusted EPS2341275063

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital129129129129
Total Reserves12698981282767736
Minority Interest------------
Total Non-Current Liabilities1222146717981698
Total Liabilities18326157981383513248
Capital Work in Progress459406205173
Total Assets18326157981383513248

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities261223726041894
Cash Flow from Investing Activities-1497-615-955-844
Cash Flow from Financing Activitie-693-1358377-1137
Net Cash Inflow / Outflow42239926-87
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 73.32.
  • 3Y Stock Price CAGR of the stock is 113.2.
  • The stock has a beta of 0.3.
  • In the last financial year, the company had an EBITDA of ₹4751 Million.
  • The company generated revenue of ₹15586 Million in the previous financial year.

Neuland Laboratories

17147.7500.1   (3%)

Investment Amount: ₹ 531275
Current Value: ₹ 1714770
Performence: 222.8%
P/L: ₹ 1183495
Top Gainers
SymbolChange%
JINDWORLD387.35(20%)
MCL63.84(20%)
BANG66.64(20%)
LINCOLN763.2(20%)
BSL285.77(19%)
Top Losers
SymbolChange%
PAR278.8(-20%)
GRANULES534.15(-10%)
AKI16.11(-10%)
MAPMYINDIA1538.1(-9%)
MALUPAPER48.24(-9%)
INDGN626.85(-6%)
STARPAPER227.82(-6%)
ZENTEC1806.4(-6%)
Similar stocks

Vimta Labs

61.3

923.85

November 3 - December 3

Innova Captab

38.8

1093.4

November 3 - December 3

Krebs Biochem.&Inds

31.4

106.58

November 3 - December 3

Jagsonpal Pharma

29.9

714.1

November 3 - December 3

Bliss GVS Pharma

29

163.84

November 3 - December 3

Panacea Biotec

28.3

446.3

November 3 - December 3

Dishman Carbogen Amc

27.7

246.72

November 3 - December 3

Supriya Lifescience

24.8

796.35

November 3 - December 3

Announcing Stock of the Month!

Stock of the Month
Stock of the Month